Philadelphia Institutions Launch Glaucoma Research Retreat - Summary - MDSpire
Conference News

Philadelphia Institutions Launch Glaucoma Research Retreat

Researchers from 5 institutions met to discuss neuroprotection, diagnostics, gene therapy, and regional collaboration.

  • May 1, 2026

  • 3 min

Share

In March, prominent ophthalmic research centers in Philadelphia convened for the inaugural All Philadelphia Glaucoma Research Retreat, aimed at enhancing collaboration among five institutions. The focus was on advancing glaucoma science through discussions on neuroprotection, diagnostics, gene therapy, and the importance of networking for research synergy. Keynote speaker Adriana Di Polo emphasized the need for coordinated efforts in tackling neurodegeneration and enhancing treatments beyond traditional approaches. The retreat showcased emerging techniques and modeling for future therapeutic development.

Original Source(s)

Philadelphia Institutions Launch Glaucoma Research Retreat

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.